The over-the-counter (OTC) cough, cold, and allergy medicine market refers to the sales and distribution of medicines that can be purchased without a prescription to treat symptoms of cough, cold, and allergies. These medicines include decongestants, antihistamines, pain relievers, and expectorants, among others. The market is segmented by product type (cough suppressant, decongestant, antihistamine, pain reliever, and expectorant), distribution channel (pharmacies, supermarkets, and online), and geography. The market is expected to grow due to increasing prevalence of respiratory and allergic disorders, growing demand for self-medication, and the availability of a wide range of products. Additionally, the market growth is driven by the increasing use of OTC cough, cold, and allergy medicines as a first line of treatment for mild symptoms, which reduces the need for prescription drugs and visits to the doctor.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=71
Key Segments Covered in the OTC Cough, Cold and Allergy Medicine Industry Survey
- By Drug Type :
- OTC Antihistamine
- OTC Expectorants
- OTC Bronchodilators
- OTC Antibiotics
- By OTC Channel :
- Pharmacies
- Drug Store
- Modern Trade
- Online
- By Dosage :
- Capsules
- Liquid
- Tablets
- Lozenges
- Others
- OTC Liquid Cough, Cold & Allergy Solutions
- OTC Liquid Cough, Cold & Allergy Drops
- OTC Liquid Cough, Cold & Allergy Granules
- OTC Liquid Cough, Cold & Allergy Syrup
- OTC Liquid Cough, Cold & Allergy Pills
- By Application :
- Babies
- Adults
- School-age Children
- By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East Africa
Following insights from Fact.MR’s global OTC cough, cold and allergy market will be important for market’s future growth
- The OTC cough, cold and allergy medicines market in Asia Pacific excluding Japan (APEJ) is anticipated to remain highly attractive throughout the assessment period. In 2017 and beyond, the region is projected to command for a noteworthy revenue share of the global market. This is primarily owing to dropping air quality and increase pollution that is resulting in higher occurrence of respiratory ailments. In addition, rapid adoption of OTC medicines owing to their convenience of purchase and cost-efficiency is facilitating the growth of the market in the region.
- On the basis of drug type, antihistamine is anticipated to command for over one-third revenues share of the market by the end of 2017. Antihistamines drugs help in restricting the histamine release from histamine-1 receptors, moreover these drugs can effectively treat watery eyes or runny nose, inflammation (redness), sneezing and swelling (edema).
- By OCT channel, pharmacies will continue to be the top OCT channel for sales of allergy, cold and cough drugs between 2017 and 2022. During the same time, the drug store segment is projected to retain its second spot.
- Based on dosage, the tablet segment is projected to command for a significant share of the market in terms of revenue and is likely to reach a valuation of nearly US$ 12,425 Mn over 2022.
Prominent Players in The Global Market
- Sanofi-Aventis
- Johnson & Johnson Service Inc.
- Reckitt Benckiser Group Plc.
- Novartis AG
- GlaxoSmithKline Plc.
- AstraZeneca Plc.
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Prestige Brands Holdings Inc.
- Procter & Gamble Co.
- Bristol-Myers Squib Co.
- Merck & Co.
- Allergen
Some of the insights and market estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides:
- Assessment of the key regulations and norms by governments and what changes are probable in the post-COVID era
- Evaluation of policies in developing and developed nations so as to understand what factors are essential in helping them bounce back to economic growth from a recent slump
- Analysis of shares and size of key product segments and the technologies that will help fuel the demands in these segments
- An overview of the direction of ongoing and future research and development, both by the private player and public institutions
- An in-depth assessment of the economic disruptions that are likely to linger on for months after the COVID-19 pandemic recedes from the world
- Technologies and healthcare infrastructures that will help understand the preparedness of various countries toward future such pandemics
- Role of next-generation technologies such as artificial intelligence in various end-use industries